Pharmaceutical Manufacturer Agrees to Pay $12.6 Million to Resolve Allegations it Provided Kickbacks Through Donations to a Third-Party Charity

/ Published May 4, 2021

Acting United States Attorney Jennifer Arbittier Williams announced that lncyte Corporation, headquartered in Delaware, has agreed to pay $12.6 million to resolve allegations that it violated the False Claims Act by using a foundation as a conduit to pay the copays of Medicare and TRICARE patients taking lncyte's drug Jakafi. TRICARE is the health care program for uniformed service members, retirees, and their families.